{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"tb-500-postherpetic","title":"TB-500 for Postherpetic Neuralgia: Evidence Review","body":"## What's breaking down\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## How these fit together\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n\n## What the evidence actually shows\nNo human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no controlled outcomes reported.\n\n## What scientists say\nResearchers note thymosin beta-4's role in peripheral nerve recovery in diabetic models, with potential via endothelial and Schwann cell effects (RegeneRx reports, 2012 and 2015). Human translation remains untested for postherpetic cases. Ocular and wound-healing trials of thymosin beta-4 exist but do not cover neuropathic pain after herpes zoster.\n\n## What people say on Reddit\nUsers in r/shingles and r/bpc_157 threads report trying BPC-157 plus TB-500 during or after shingles flares. One user stated they used the combination for two months with \"no issues.\" Another thread links peptides to nerve regeneration discussions for postherpetic neuralgia, but experiences remain individual and unverified. No large-scale user consensus emerges.\n\n## What people say on X\nSearches yielded no prominent public posts detailing TB-500 specifically for postherpetic neuralgia on X.\n\n## What we do not know\nDirect human data for TB-500 in postherpetic neuralgia is absent. It is unknown whether effects seen in diabetic neuropathy models translate to viral nerve injury. Long-term outcomes, optimal protocols, and interactions with antivirals or standard neuropathic pain treatments remain unstudied in this context.\n\n## Safety and limits\nTB-500 is researched in preclinical settings for repair pathways. No large human safety databases exist for this use. Individual responses vary. This is not medical advice — consult qualified professionals for personal health decisions.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-postherpetic/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human clinical trials exist for TB-500 in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Provides the main preclinical data on nerve repair relevant to neuropathic pain.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Grounds the if-then logic for repair pathways.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Captures real-world discussion separate from studies.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://coremedicalwellness.com/peptide-therapy-pain-management/","title":"Peptide Therapy for Pain Management and Healing","quote":"TB-500 : The Mobility Enhancer. A synthetic version of thymosin beta-4 , TB-500 focuses on enhancing cell migration and reducing fibrosis ...","summary":"Clinic overview of TB-500 mechanisms; no PHN-specific trials mentioned.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"6d10e858307b6f090034a44f00b692a1fce2e194bab30c7a90c330f99ac6ecc4"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3533234/","title":"Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice","quote":"Tβ4 improves peripheral nerve function of diabetic peripheral neuropathy in db/db mice.","summary":"2012 mouse study on diabetic neuropathy recovery.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"6d10e858307b6f090034a44f00b692a1fce2e194bab30c7a90c330f99ac6ecc4","hash":"751d895b3835f7a19c66743cf6f75f216c8b055c87a4e92dc995329184ff528a"},{"id":"s3","type":"news","url":"https://www.prnewswire.com/news-releases/researchers-report-that-long-term-administration-of-thymosin-b4-in-a-diabetic-animal-model-prevents-progression-of-peripheral-neuropathy-and-restores-sciatic-nerve-function-300079982.html","title":"Researchers Report that Long-Term Administration of Thymosin B4 in a Diabetic Animal Model Prevents Progression of Peripheral Neuropathy","quote":"diabetic mice treated long-term with Thymosin B4 (TB4) have significantly improved motor and sensory function in the sciatic nerve","summary":"2015 press release summarizing mouse neuropathy findings.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"verified","prev":"751d895b3835f7a19c66743cf6f75f216c8b055c87a4e92dc995329184ff528a","hash":"993eaecf5c96ab23b708f83295f9de1e52370d97e3874954950a20c9e103d04a"},{"id":"s4","type":"medical","url":"https://activelifepaincenter.com/revolutionizing-recovery-how-dr-lundquist-is-using-bpc-157-tb-500-and-regenerative-therapies-to-accelerate-healing/","title":"How Dr. Lundquist is Using BPC-157, TB-500 ...","quote":"TB-500 works by increasing a protein called actin, which is vital for cellular movement and repair.","summary":"Description of TB-500 mechanisms in pain and healing context.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"993eaecf5c96ab23b708f83295f9de1e52370d97e3874954950a20c9e103d04a","hash":"39c07c357c320658044da30cc89a500df75a2912b1f83dc471f44e08ca2a7a90"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/shingles/comments/16qjxwo/had_shingles_two_years_ago_recent_flair_up_6/","title":"Had Shingles Two years ago, recent flair up 6 months ...","quote":"I did bpc and tb 500 , for two months. No issues.","summary":"User anecdote on TB-500 use post-shingles.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"39c07c357c320658044da30cc89a500df75a2912b1f83dc471f44e08ca2a7a90","hash":"ca871e61695d2324c708692601620b0f18ba7427281452e6a3e1ec96384bf36e"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1mmkbbp/bcp157tb500_shingles/","title":"BCP157/TB500 shingles?","quote":"The rash stayed around for a few weeks, but with the anti virals and it being a mild case, no more pain in 6 days.","summary":"Additional Reddit context on peptide use with shingles.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"ca871e61695d2324c708692601620b0f18ba7427281452e6a3e1ec96384bf36e","hash":"d3cf2646ee18f6a8b4f88482095cb57ea38ed738cbb8f444aa38655ac044730a"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:33:00.410Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 for Postherpetic Neuralgia: Evidence Review","register":"source_ledger","body":"## What's breaking down\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## How these fit together\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n\n## What the evidence actually shows\nNo human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no controlled outcomes reported.\n\n## What scientists say\nResearchers note thymosin beta-4's role in peripheral nerve recovery in diabetic models, with potential via endothelial and Schwann cell effects (RegeneRx reports, 2012 and 2015). Human translation remains untested for postherpetic cases. Ocular and wound-healing trials of thymosin beta-4 exist but do not cover neuropathic pain after herpes zoster.\n\n## What people say on Reddit\nUsers in r/shingles and r/bpc_157 threads report trying BPC-157 plus TB-500 during or after shingles flares. One user stated they used the combination for two months with \"no issues.\" Another thread links peptides to nerve regeneration discussions for postherpetic neuralgia, but experiences remain individual and unverified. No large-scale user consensus emerges.\n\n## What people say on X\nSearches yielded no prominent public posts detailing TB-500 specifically for postherpetic neuralgia on X.\n\n## What we do not know\nDirect human data for TB-500 in postherpetic neuralgia is absent. It is unknown whether effects seen in diabetic neuropathy models translate to viral nerve injury. Long-term outcomes, optimal protocols, and interactions with antivirals or standard neuropathic pain treatments remain unstudied in this context.\n\n## Safety and limits\nTB-500 is researched in preclinical settings for repair pathways. No large human safety databases exist for this use. Individual responses vary. This is not medical advice — consult qualified professionals for personal health decisions.","claims":[{"id":"c1","text":"No human clinical trials exist for TB-500 in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Provides the main preclinical data on nerve repair relevant to neuropathic pain.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Grounds the if-then logic for repair pathways.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Captures real-world discussion separate from studies.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://coremedicalwellness.com/peptide-therapy-pain-management/","title":"Peptide Therapy for Pain Management and Healing","quote":"TB-500 : The Mobility Enhancer. A synthetic version of thymosin beta-4 , TB-500 focuses on enhancing cell migration and reducing fibrosis ...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3533234/","title":"Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice","quote":"Tβ4 improves peripheral nerve function of diabetic peripheral neuropathy in db/db mice.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"news","url":"https://www.prnewswire.com/news-releases/researchers-report-that-long-term-administration-of-thymosin-b4-in-a-diabetic-animal-model-prevents-progression-of-peripheral-neuropathy-and-restores-sciatic-nerve-function-300079982.html","title":"Researchers Report that Long-Term Administration of Thymosin B4 in a Diabetic Animal Model Prevents Progression of Peripheral Neuropathy","quote":"diabetic mice treated long-term with Thymosin B4 (TB4) have significantly improved motor and sensory function in the sciatic nerve","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"medical","url":"https://activelifepaincenter.com/revolutionizing-recovery-how-dr-lundquist-is-using-bpc-157-tb-500-and-regenerative-therapies-to-accelerate-healing/","title":"How Dr. Lundquist is Using BPC-157, TB-500 ...","quote":"TB-500 works by increasing a protein called actin, which is vital for cellular movement and repair.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/shingles/comments/16qjxwo/had_shingles_two_years_ago_recent_flair_up_6/","title":"Had Shingles Two years ago, recent flair up 6 months ...","quote":"I did bpc and tb 500 , for two months. No issues.","link_status":"ok","quote_status":"unverified"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1mmkbbp/bcp157tb500_shingles/","title":"BCP157/TB500 shingles?","quote":"The rash stayed around for a few weeks, but with the anti virals and it being a mild case, no more pain in 6 days.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":12558,"tokens_out":2888,"cost":0.0229175,"prev_hash":"genesis","hash":"ea93ba94d71d55f21edc21f164db6acbc1edc7a4c6ca8f32fc3903f73ea004ba"}],"provenance":[{"ts":"2026-06-29T23:33:00.410Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Postherpetic\nSlug: tb-500-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stac","response":"{\n  \"slug\": \"tb-500-postherpetic\",\n  \"title\": \"TB-500 for Postherpetic Neuralgia: Evidence Review\",\n  \"body\": \"## What's breaking down\\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\\n\\n## Why TB-500 might help you\\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\n## How these fit together\\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n\\n## What the evidence actually shows\\nNo human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no control","tokens_in":12558,"tokens_out":2888,"cost":0,"prev":"genesis","hash":"be75cf2ee3ffa48aa5fadb014d6c3416569ddec013ad43b4c04dc9d498e700e4"},{"ts":"2026-07-17T02:42:18.017Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-postherpetic","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"be75cf2ee3ffa48aa5fadb014d6c3416569ddec013ad43b4c04dc9d498e700e4","hash":"81db4b8853871e12f8ae385b34695076d910a8f64de3618d7997a88e9118ba45"}],"energy":{"passes":2,"tokens_in":12558,"tokens_out":2888,"tokens_total":15446,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"81db4b8853871e12f8ae385b34695076d910a8f64de3618d7997a88e9118ba45"},"posted_at":"2026-06-29T21:33:29.205Z","created_at":"2026-06-29T21:33:29.205Z","updated_at":"2026-07-17T02:42:18.017Z","machine":{"shape":"article.machine/v1","slug":"tb-500-postherpetic","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-postherpetic","json":"https://miscsubjects.com/api/articles/tb-500-postherpetic","bundle":"https://miscsubjects.com/api/articles/tb-500-postherpetic/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-postherpetic/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-postherpetic","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-postherpetic\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-postherpetic\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-postherpetic/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-postherpetic\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-postherpetic | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-postherpetic","json":"/api/articles/tb-500-postherpetic","markdown":"/api/articles/tb-500-postherpetic/bundle?format=markdown","skill":"/api/articles/tb-500-postherpetic/skill","topology":"/api/articles/tb-500-postherpetic/topology","versions":"/api/articles/tb-500-postherpetic/revisions","invocations":"/api/articles/tb-500-postherpetic/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-postherpetic","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"0d724d6cb00b311a24aa8b8114f7a86c7f496f4d413561fcb9176e1fd7c1b2d9","object":{"object_type":"article-object","identity":{"id":"article:tb-500-postherpetic","slug":"tb-500-postherpetic","title":"TB-500 for Postherpetic Neuralgia: Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/tb-500-postherpetic","role":"explain","audience":"human"},"skill":{"route":"/api/articles/tb-500-postherpetic/skill","role":"direct behavior","audience":"model","content":"---\nname: tb-500-postherpetic\ndescription: Apply the TB-500 for Postherpetic Neuralgia: Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# TB-500 for Postherpetic Neuralgia: Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/tb-500-postherpetic). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/tb-500-postherpetic.\n- Read claims and relationships at /api/articles/tb-500-postherpetic/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Postherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes\n\n## Representations\n\n- Human: /a/tb-500-postherpetic\n- JSON: /api/articles/tb-500-postherpetic\n- Relationships: /api/articles/tb-500-postherpetic/topology\n- History: /api/articles/tb-500-postherpetic/revisions\n"},"json":{"route":"/api/articles/tb-500-postherpetic","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/tb-500-postherpetic/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","tb","500","postherpetic"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/tb-500-postherpetic/invocations?status=success","failure_events":"/api/articles/tb-500-postherpetic/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"tb-500-postherpetic","title":"TB-500 for Postherpetic Neuralgia: Evidence Review","body":"## What's breaking down\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## How these fit together\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n\n## What the evidence actually shows\nNo human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no controlled outcomes reported.\n\n## What scientists say\nResearchers note thymosin beta-4's role in peripheral nerve recovery in diabetic models, with potential via endothelial and Schwann cell effects (RegeneRx reports, 2012 and 2015). Human translation remains untested for postherpetic cases. Ocular and wound-healing trials of thymosin beta-4 exist but do not cover neuropathic pain after herpes zoster.\n\n## What people say on Reddit\nUsers in r/shingles and r/bpc_157 threads report trying BPC-157 plus TB-500 during or after shingles flares. One user stated they used the combination for two months with \"no issues.\" Another thread links peptides to nerve regeneration discussions for postherpetic neuralgia, but experiences remain individual and unverified. No large-scale user consensus emerges.\n\n## What people say on X\nSearches yielded no prominent public posts detailing TB-500 specifically for postherpetic neuralgia on X.\n\n## What we do not know\nDirect human data for TB-500 in postherpetic neuralgia is absent. It is unknown whether effects seen in diabetic neuropathy models translate to viral nerve injury. Long-term outcomes, optimal protocols, and interactions with antivirals or standard neuropathic pain treatments remain unstudied in this context.\n\n## Safety and limits\nTB-500 is researched in preclinical settings for repair pathways. No large human safety databases exist for this use. Individual responses vary. This is not medical advice — consult qualified professionals for personal health decisions.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-postherpetic/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human clinical trials exist for TB-500 in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Provides the main preclinical data on nerve repair relevant to neuropathic pain.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Grounds the if-then logic for repair pathways.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Captures real-world discussion separate from studies.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://coremedicalwellness.com/peptide-therapy-pain-management/","title":"Peptide Therapy for Pain Management and Healing","quote":"TB-500 : The Mobility Enhancer. A synthetic version of thymosin beta-4 , TB-500 focuses on enhancing cell migration and reducing fibrosis ...","summary":"Clinic overview of TB-500 mechanisms; no PHN-specific trials mentioned.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"6d10e858307b6f090034a44f00b692a1fce2e194bab30c7a90c330f99ac6ecc4"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3533234/","title":"Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice","quote":"Tβ4 improves peripheral nerve function of diabetic peripheral neuropathy in db/db mice.","summary":"2012 mouse study on diabetic neuropathy recovery.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"6d10e858307b6f090034a44f00b692a1fce2e194bab30c7a90c330f99ac6ecc4","hash":"751d895b3835f7a19c66743cf6f75f216c8b055c87a4e92dc995329184ff528a"},{"id":"s3","type":"news","url":"https://www.prnewswire.com/news-releases/researchers-report-that-long-term-administration-of-thymosin-b4-in-a-diabetic-animal-model-prevents-progression-of-peripheral-neuropathy-and-restores-sciatic-nerve-function-300079982.html","title":"Researchers Report that Long-Term Administration of Thymosin B4 in a Diabetic Animal Model Prevents Progression of Peripheral Neuropathy","quote":"diabetic mice treated long-term with Thymosin B4 (TB4) have significantly improved motor and sensory function in the sciatic nerve","summary":"2015 press release summarizing mouse neuropathy findings.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"verified","prev":"751d895b3835f7a19c66743cf6f75f216c8b055c87a4e92dc995329184ff528a","hash":"993eaecf5c96ab23b708f83295f9de1e52370d97e3874954950a20c9e103d04a"},{"id":"s4","type":"medical","url":"https://activelifepaincenter.com/revolutionizing-recovery-how-dr-lundquist-is-using-bpc-157-tb-500-and-regenerative-therapies-to-accelerate-healing/","title":"How Dr. Lundquist is Using BPC-157, TB-500 ...","quote":"TB-500 works by increasing a protein called actin, which is vital for cellular movement and repair.","summary":"Description of TB-500 mechanisms in pain and healing context.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"993eaecf5c96ab23b708f83295f9de1e52370d97e3874954950a20c9e103d04a","hash":"39c07c357c320658044da30cc89a500df75a2912b1f83dc471f44e08ca2a7a90"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/shingles/comments/16qjxwo/had_shingles_two_years_ago_recent_flair_up_6/","title":"Had Shingles Two years ago, recent flair up 6 months ...","quote":"I did bpc and tb 500 , for two months. No issues.","summary":"User anecdote on TB-500 use post-shingles.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"39c07c357c320658044da30cc89a500df75a2912b1f83dc471f44e08ca2a7a90","hash":"ca871e61695d2324c708692601620b0f18ba7427281452e6a3e1ec96384bf36e"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1mmkbbp/bcp157tb500_shingles/","title":"BCP157/TB500 shingles?","quote":"The rash stayed around for a few weeks, but with the anti virals and it being a mild case, no more pain in 6 days.","summary":"Additional Reddit context on peptide use with shingles.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:32:58.845Z","link_status":"ok","quote_status":"unverified","prev":"ca871e61695d2324c708692601620b0f18ba7427281452e6a3e1ec96384bf36e","hash":"d3cf2646ee18f6a8b4f88482095cb57ea38ed738cbb8f444aa38655ac044730a"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:33:00.410Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 for Postherpetic Neuralgia: Evidence Review","register":"source_ledger","body":"## What's breaking down\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## How these fit together\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n\n## What the evidence actually shows\nNo human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no controlled outcomes reported.\n\n## What scientists say\nResearchers note thymosin beta-4's role in peripheral nerve recovery in diabetic models, with potential via endothelial and Schwann cell effects (RegeneRx reports, 2012 and 2015). Human translation remains untested for postherpetic cases. Ocular and wound-healing trials of thymosin beta-4 exist but do not cover neuropathic pain after herpes zoster.\n\n## What people say on Reddit\nUsers in r/shingles and r/bpc_157 threads report trying BPC-157 plus TB-500 during or after shingles flares. One user stated they used the combination for two months with \"no issues.\" Another thread links peptides to nerve regeneration discussions for postherpetic neuralgia, but experiences remain individual and unverified. No large-scale user consensus emerges.\n\n## What people say on X\nSearches yielded no prominent public posts detailing TB-500 specifically for postherpetic neuralgia on X.\n\n## What we do not know\nDirect human data for TB-500 in postherpetic neuralgia is absent. It is unknown whether effects seen in diabetic neuropathy models translate to viral nerve injury. Long-term outcomes, optimal protocols, and interactions with antivirals or standard neuropathic pain treatments remain unstudied in this context.\n\n## Safety and limits\nTB-500 is researched in preclinical settings for repair pathways. No large human safety databases exist for this use. Individual responses vary. This is not medical advice — consult qualified professionals for personal health decisions.","claims":[{"id":"c1","text":"No human clinical trials exist for TB-500 in postherpetic neuralgia.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the specific condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Mouse studies show thymosin beta-4 improves sciatic nerve function and conduction velocities in diabetic peripheral neuropathy models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Provides the main preclinical data on nerve repair relevant to neuropathic pain.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 effects on actin regulation, cell migration, and inflammation clearance in tissue repair.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Grounds the if-then logic for repair pathways.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report trying TB-500 (often stacked with BPC-157) after shingles with mixed personal notes but no controlled data.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s5","s6"],"source_status":"sourced","why_material":"Captures real-world discussion separate from studies.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:33:00.048Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://coremedicalwellness.com/peptide-therapy-pain-management/","title":"Peptide Therapy for Pain Management and Healing","quote":"TB-500 : The Mobility Enhancer. A synthetic version of thymosin beta-4 , TB-500 focuses on enhancing cell migration and reducing fibrosis ...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3533234/","title":"Thymosin β4 Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice","quote":"Tβ4 improves peripheral nerve function of diabetic peripheral neuropathy in db/db mice.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"news","url":"https://www.prnewswire.com/news-releases/researchers-report-that-long-term-administration-of-thymosin-b4-in-a-diabetic-animal-model-prevents-progression-of-peripheral-neuropathy-and-restores-sciatic-nerve-function-300079982.html","title":"Researchers Report that Long-Term Administration of Thymosin B4 in a Diabetic Animal Model Prevents Progression of Peripheral Neuropathy","quote":"diabetic mice treated long-term with Thymosin B4 (TB4) have significantly improved motor and sensory function in the sciatic nerve","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"medical","url":"https://activelifepaincenter.com/revolutionizing-recovery-how-dr-lundquist-is-using-bpc-157-tb-500-and-regenerative-therapies-to-accelerate-healing/","title":"How Dr. Lundquist is Using BPC-157, TB-500 ...","quote":"TB-500 works by increasing a protein called actin, which is vital for cellular movement and repair.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"reddit","url":"https://www.reddit.com/r/shingles/comments/16qjxwo/had_shingles_two_years_ago_recent_flair_up_6/","title":"Had Shingles Two years ago, recent flair up 6 months ...","quote":"I did bpc and tb 500 , for two months. No issues.","link_status":"ok","quote_status":"unverified"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1mmkbbp/bcp157tb500_shingles/","title":"BCP157/TB500 shingles?","quote":"The rash stayed around for a few weeks, but with the anti virals and it being a mild case, no more pain in 6 days.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":12558,"tokens_out":2888,"cost":0.0229175,"prev_hash":"genesis","hash":"ea93ba94d71d55f21edc21f164db6acbc1edc7a4c6ca8f32fc3903f73ea004ba"}],"provenance":[{"ts":"2026-06-29T23:33:00.410Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Postherpetic\nSlug: tb-500-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stac","response":"{\n  \"slug\": \"tb-500-postherpetic\",\n  \"title\": \"TB-500 for Postherpetic Neuralgia: Evidence Review\",\n  \"body\": \"## What's breaking down\\nPostherpetic neuralgia develops after a shingles outbreak caused by the varicella-zoster virus. The virus damages sensory nerves, leaving persistent inflammation, disrupted nerve signaling, and impaired repair processes. Repair cells may fail to reach damaged axons efficiently, inflammation lingers instead of clearing, and the actin cytoskeleton in cells can become disorganized, slowing structural rebuilding. These layers keep the pain chronic rather than allowing full resolution.\\n\\n## Why TB-500 might help you\\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\n## How these fit together\\nSingle-compound focus — TB-500 targets inflammation clearance / repair-cell migration. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n\\n## What the evidence actually shows\\nNo human clinical trials exist for TB-500 in postherpetic neuralgia. Preclinical animal studies in diabetic peripheral neuropathy models (mice) show thymosin beta-4 improving sciatic nerve function, motor and sensory conduction velocities, and neurovascular recovery (Wang et al., 2012, Neurobiol Dis). These are rat/mouse studies only and do not prove effects in viral nerve damage like PHN. Mechanistic data link thymosin beta-4 to actin regulation and cell migration in tissue repair models. Anecdotal reports on Reddit mention users trying TB-500 (often with BPC-157) after shingles, with some noting no added issues but no control","tokens_in":12558,"tokens_out":2888,"cost":0,"prev":"genesis","hash":"be75cf2ee3ffa48aa5fadb014d6c3416569ddec013ad43b4c04dc9d498e700e4"},{"ts":"2026-07-17T02:42:18.017Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-postherpetic","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"be75cf2ee3ffa48aa5fadb014d6c3416569ddec013ad43b4c04dc9d498e700e4","hash":"81db4b8853871e12f8ae385b34695076d910a8f64de3618d7997a88e9118ba45"}],"energy":{"passes":2,"tokens_in":12558,"tokens_out":2888,"tokens_total":15446,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"81db4b8853871e12f8ae385b34695076d910a8f64de3618d7997a88e9118ba45"},"posted_at":"2026-06-29T21:33:29.205Z","created_at":"2026-06-29T21:33:29.205Z","updated_at":"2026-07-17T02:42:18.017Z","machine":{"shape":"article.machine/v1","slug":"tb-500-postherpetic","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-postherpetic","json":"https://miscsubjects.com/api/articles/tb-500-postherpetic","bundle":"https://miscsubjects.com/api/articles/tb-500-postherpetic/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-postherpetic/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-postherpetic","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-postherpetic\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-postherpetic\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-postherpetic/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-postherpetic\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-postherpetic | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-postherpetic","json":"/api/articles/tb-500-postherpetic","markdown":"/api/articles/tb-500-postherpetic/bundle?format=markdown","skill":"/api/articles/tb-500-postherpetic/skill","topology":"/api/articles/tb-500-postherpetic/topology","versions":"/api/articles/tb-500-postherpetic/revisions","invocations":"/api/articles/tb-500-postherpetic/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-postherpetic","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"0d724d6cb00b311a24aa8b8114f7a86c7f496f4d413561fcb9176e1fd7c1b2d9"}}}